- Home
- / Hypera Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hypera Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
R$23.9
2024-10-28
Market Capitalization
R$17.3 B
2024-10-28
Revenue
R$7.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| BRL | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.7B | 3.3B | 4.1B | 5.9B | 7.5B | 7.9B | 7.4B | 7.7B |
| Cost of goods sold | 971.7M | 1.1B | 1.3B | 2.0B | 2.6B | 2.7B | 2.8B | 2.8B |
| Gross profit | 2.8B | 2.8B | 3.0B | 4.0B | 5.0B | 5.3B | 4.7B | 4.9B |
| Gross profit margin, % | 75.7% | 85.5% | 73.5% | 67.2% | 65.6% | 66.5% | 63.7% | 63.0% |
| Operating expense total | 1.5B | 1.7B | 1.6B | 2.3B | 2.3B | 2.5B | 2.7B | 2.8B |
| Depreciation and amortization | 87.3M | 96.1M | 123.5M | 132.9M | 171.1M | 235.5M | 276.8M | 305.0M |
| EBITDA | 1.3B | 1.1B | 1.4B | 1.7B | 2.6B | 2.8B | 2.1B | 2.1B |
| EBITDA margin, % | 35.2% | 34.7% | 34.4% | 28.1% | 35.0% | 34.8% | 28.2% | 26.9% |
| EBIT | 1.2B | 1.0B | 1.3B | 1.5B | 2.5B | 2.5B | 1.8B | 1.8B |
| EBIT margin, % | 32.9% | 31.8% | 31.3% | 25.8% | 32.7% | 31.8% | 24.5% | 22.9% |
| Interest income | 85.8M | 96.2M | 26.9M | 35.9M | 70.8M | 58.7M | 35.1M | 47.6M |
| Interest expense | 72.7M | 68.0M | 205.6M | 416.5M | 1.1B | 1.2B | 1.1B | 1.1B |
| Pre tax profit | 1.2B | 1.1B | 1.2B | 1.2B | 1.6B | 1.5B | 979.2M | 900.1M |
| Income tax expense | 95.3M | (101.5M) | (89.1M) | (121.0M) | (100.6M) | (141.6M) | (353.8M) | (290.8M) |
| Net Income | 1.1B | 1.2B | 1.3B | 1.3B | 1.7B | 1.7B | 1.3B | 1.2B |